Search This Blog

Monday, January 13, 2025

MSNBC Attacks Trump And Musk For Telling The Truth About Suspicious LA Fires

 When leftists are faced with the inevitable consequences of their own political policies it's rare for them to sit down and reflect on their failures.  Instead, they double down and refuse to admit any fault whatsoever.  They will make excuse after excuse and blame scapegoat after scapegoat.  In a city like Los Angeles and a state like California which have been micro-managed by Democrats for decades with zero input from conservatives, somehow, they still find a way to attack their ideological opposition in the wake of a disaster.

Leftists do not admit wrongdoing when criticized.  Rather, their default is to go on the offensive against their critics in an attempt to flip the table and change the subject.  They do this so often that one begins to wonder if they care at all about the destruction they have caused?  Maybe their policies did not fail?  Maybe destruction is exactly what they want?

Former Biden Administration Press Secretary Jen Psaki took to MSNBC recently to dismiss claims of mismanagement on the part of the LA government and their fire response teams.  Instead of admitting to the reality that the area had little to no water and limited equipment to fight the fires because of terrible planning, Psaki tries to make the event all about Donald Trump, Elon Musk and even Alex Jones.

It should be noted that Psaki once again spread lies about Trump's position on FEMA and Hurricane Helene as a way to diminish his valid accusations against LA and CA management policies.  It is a fact that FEMA funds were widely spent by the Biden Admin and funneled into the pockets of illegal immigrants instead of being used to help American citizens in need.  Democrats continue to spread falsehoods about this even though they have been debunked.

Psaki then accuses Trump and Elon Musk of spreading disinformation when it comes to the city's DEI initiatives and their crippling effects on the government's readiness.  It's not just about LA's first female lesbian fire chief, Kristine Crowley.  There's also the issue of LA's mayor, Karen Bass, who cut at least $17 million from the LAFD budget for 2024-2025 with another $48 million in cuts on the way.  Claims of budget increases revolve around funding to improve salaries and benefits.  New money did not go to fire fighting infrastructure, a problem which Fire Chief Kristine Crowley warned about.

Then there's the issue of DEI hires like LA Assistant Fire Chief Kristine Larson, who argued that she should not have to carry a man out of a fire because he 'got himself in the wrong place'. 

No one cares if the firefighter saving their life "looks like them".  

And how about the LA Water Chief, who was in charge of a water collection infrastructure that had little to no water when the fires erupted?  Is she a DEI hire?  Decide for yourself...

LA is, at the very least, a victim of its own DEI incompetence.  Whether or not there is a conspiracy to sabotage US infrastructure, if proper procedures had been followed and resources gathered the fires would not have spread as quickly or as far as they did.  The bottom line?  LA had nowhere near enough resources. 

Democrats have responded by claiming that "no water system" is capable of fighting the kind of fires seen in LA.  If this is truly the case, then why didn't they use funds to create a system that could handle a major fire?  It's always the same with leftists - all excuses and no answers.    

So far the fires have done up to $130 billion in damage, burning more than 12,000 structures from homes to businesses and scorching tens of thousands of acres.  Some of America's most valuable real estate is in ashes and the public is left bewildered.

Democrats, as usual, have tried to go with the "global warming" theory, until at least two men were arrested with possible charges of arson.  One of those men, Jose Carranza-Escobar, has already admitted to starting at least one blaze in the Azuza area.  Very little information has been released on Escobar other than he is a "transient" according to police.  The other man has been identified as Juan Manuel Sierra-Leyvaan alleged illegal immigrant arrested for starting fires in the Kenneth area.

Other reports indicate some odd behaviors and coincidences, including people throwing full containers of gasoline onto highways (allowing fires to more easily spread across the road).  If this is true, it suggests possible coordination to start or worsen the fires.  Of course, random psychotic behavior could also be blamed. 

More investigation is needed, but arson is notoriously difficult to prove.  What is not random is the complete lack of practical preparedness on the part of the city government.  For now all that can be done is to put the current LA and CA officials under a microscope and force them to resign or change their methods; methods which clearly do not work.  Democrats prefer that this incident be forgotten and that business carry on a usual once the ashes are swept away (which is exactly what happened after the Maui fires).  This cannot be allowed to happen again. 

https://www.zerohedge.com/political/msnbc-attacks-trump-and-musk-telling-truth-about-suspicious-la-fires

Stifel Nicolaus Lowers RxSight (NASDAQ:RXST) Price Target to $35

 RxSight had its price objective decreased by equities research analysts at Stifel Nicolaus from $40.00 to $35.00 in a report released on Monday,Benzinga reports. The brokerage currently has a "hold" rating on the stock. Stifel Nicolaus' target price points to a potential upside of 22.98% from the stock's previous close.

https://www.marketbeat.com/instant-alerts/stifel-nicolaus-lowers-rxsight-nasdaqrxst-price-target-to-3500-2025-01-13/

Salarius Pharma, Decoy Therapeutics in Definitive Merger Agreement

 Decoy’s proprietary IMP3ACT™ peptide conjugate drug design and manufacturing platform leverages machine learning (ML) and artificial intelligence (AI) tools

Decoy is leveraging non-dilutive funding and equivalents from federal governments, corporations and The Bill & Melinda Gates Foundation totaling approximately $7 million

Combined company expects to accelerate clinical development of novel peptide conjugate therapeutics for the treatment of respiratory viruses and cancer

The closing consideration will consist primarily of nonvoting preferred stock of Salarius, and it is expected that following closing and a post-closing stockholder vote to approve the conversion of the preferred shares into common stock, Decoy investors would own approximately 86% of the outstanding shares of the merged company and Salarius stockholders would own approximately 14% of the outstanding shares, subject to adjustment, in each case exclusive of any shares issued in any subsequent financing. For further details on the transaction and conditions for closing of the merger, please refer to the Form 8-K Salarius Pharmaceuticals filed with the U.S. Securities and Exchange Commission (SEC) in conjunction with this press release at www.sec.gov.

https://www.globenewswire.com/news-release/2025/01/13/3008457/0/en/Salarius-Pharmaceuticals-and-Decoy-Therapeutics-Announce-Definitive-Merger-Agreement.html

Phio Pharma Promising Results of Second Cohort in Squamous Cell Carcinoma

 

Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio today announced pathologic responses for patients enrolled in the 2nd cohort, which includes 2 patients with a complete response or 100% tumor clearance.

Phio's ongoing Phase 1b clinical study (NCT 06014086) is designed to evaluate the safety and tolerability of neoadjuvant use of intratumoral PH-762 in Stages 1, 2 and 4 cutaneous squamous cell carcinoma, Stage 4 melanoma and Stage 4 Merkel cell carcinoma.

Of the patients enrolled to date, 6 patients were diagnosed with cutaneous squamous cell carcinoma and 1 patient was diagnosed with metastatic melanoma. At Day 36 (tumor excision), while patients in the first cohort had stable disease, results are now available for the 4 patients who completed treatment in the 2nd cohort:

  • Complete response (100% tumor clearance) is reported for 2 patients with cutaneous squamous cell carcinoma. Partial response (90% tumor clearance) is reported for 1 patient with cutaneous squamous cell carcinoma and 1 patient had stable disease, having not progressed.

There have been no dose-limiting toxicities, or clinically relevant treatment-emergent adverse events in the patients receiving intratumoral PH-762. The intratumoral injections have been well tolerated.

https://www.newsfilecorp.com/release/236693/Phio-Pharmaceuticals-Announces-Promising-Results-of-Second-Cohort-from-Its-Ongoing-Clinical-Study-of-PH762

NovoCure prelims, at JPM

 Preliminary full year 2024 net revenues of $605 million and fourth quarter net revenues of $161 million

Novocure to present at the 43rd Annual J.P. Morgan Healthcare Conference at 9:00 a.m. PST on Wednesday, January 15, 2025

https://www.businesswire.com/news/home/20250113669334/en/

SI-BONE prelims

 Fourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%

Achieved adjusted EBITDA profitability in the fourth quarter

HealthEquity Record Year-End HSA Sales Outlook, at J.P. Morgan

 HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced estimates of HSAs, HSA Assets and Total Accounts for its fiscal year ending January 31, 2025, reflecting a strong sales year with record New HSAs from Sales and strong custodial HSA Asset growth.

  • Estimated HSAs to be approximately 9.8 million by January 31, 2025, up from 8.7 million a year earlier.
  • Estimated HSA Assets to be approximately $31 billion, up from $25.2 billion at the end of fiscal year 2024, with approximately $17 billion of HSA Cash. Invested balances included in the estimated assets are subject to market fluctuation.
  • Estimated Total Accounts to be approximately 17 million compared to 15.7 million at the end of fiscal year 2024.
At the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 8:15 am Pacific Time in the Elizabethan Room of the St. Francis Hotel.

An audio webcast of the presentation along with a copy of the presentation slides will be available and archived on HealthEquity’s investor relations website at http://ir.healthequity.com.

https://www.globenewswire.com/news-release/2025/01/13/3008611/32142/en/HealthEquity-Announces-Record-Year-End-HSA-Sales-Outlook-Presentation-at-J-P-Morgan-Healthcare-Conference.html